Director/PDMR Shareholding

Summary by AI ^BETAClose X

Robert Walters plc announced that Leslie Van De Walle, the Board Chair, purchased 30,000 ordinary shares at an average price of 96.4 pence per share on April 27, 2026, for a total consideration of £28,920. This transaction increases Leslie Van De Walle's total holding in the company to 108,000 ordinary shares.

Disclaimer*

Robert Walters PLC

28 April 2026

Robert Walters plc

("Robert Walters" or the "Company")

28 April 2026

Notification and public disclosure of transaction by PDMR

The Company has been notified that Leslie Van De Walle, Board Chair of the Company, purchased 30,000 ordinary shares of 20p each in the Company ("Ordinary Shares") on 27 April 2026 at an average price of 96.4 pence per share. As a result, Leslie Van De Walle's holding in the Company is now 108,000 Ordinary Shares.

Appendix

1.	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name	Leslie Van De Walle
2.	Reason for the notification
(a)	Position/status	Board Chair
(b)	Initial notification/ Amendment	Initial notification
3.	Details of the issuer
(a)	Name	Robert Walters plc
(b)	LEI	213800LIE15BDEN3VW43
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)	Description of the Financial Instrument	Ordinary Shares of 20p each
(b)	Identification code of the Financial Instrument	ISIN Code : GB0008475088
(c)	Nature of the transaction	On-market purchase of Ordinary Shares in Robert Walters plc
(d)	Price(s) and volume(s)	Price(s)	Volume(s)
		96.4 pence	30,000

(e)	Aggregated information - Aggregated volume - Price	30,000 £28,920
(f)	Date of the transaction	27 April 2026
(g)	Place of the transaction	London Stock Exchange

Enquiries

Robert Walters plc

Dami Tanimowo - Head of IR & Group Strategic Analysis

dami.tanimowo@robertwalters.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END